DEFA14C: Ludwig Enterprises to Rebrand as Revealia, Inc. Following Shareholder Approval

Ludwig Enterprises, Inc. will change its corporate name to Revealia, Inc. after securing shareholder approval via written consent.

Summary

• Ludwig Enterprises, Inc. is changing its name to Revealia, Inc.
• The name change was approved by the Board of Directors and holders of 81.48% of the company's voting power on August 13, 2024.
• The amendment to the Articles of Incorporation will be filed no sooner than 20 days after the information statement is mailed to shareholders.
• The company believes the new name better reflects its current and future business operations and strategies, particularly in mRNA genomics and machine learning AI technology.
• The name change is expected to be effective on or about September 30, 2024.
• Shareholders are not required to exchange their existing stock certificates.
• The company expects to receive FINRA approval for the name change after the effective date.
• The company will file a Form 8-K with the SEC to announce the new CUSIP number and trading symbol.
• The company's mission is to identify, monitor, and create solutions to prevent chronic inflammation.

Sentiment

Score: 7

Explanation: The document is a standard corporate communication regarding a name change, which is generally neutral. The company expresses optimism about the future alignment of the new name with its business strategy, contributing to a slightly positive sentiment.

Positives

• The company believes the name change will better reflect its current and future business operations and strategies.
• The company's mission is to identify, monitor and create solutions to prevent chronic inflammation, the causative agent of illnesses, such as cancer and heart disease, which are responsible for more than 50% of deaths worldwide.

Risks

• The corporate name change requires approval by FINRA for trading purposes.
• The corporate name change may result in a change in the CUSIP number for the company's common stock.

Future Outlook

The company anticipates that the name change will better align with its current and future business operations and strategies in mRNA genomics and machine learning AI technology.

Management Comments

• The Companys Board of Directors believes that it is in the best interest of the shareholders to change the corporate name of the Company.

Industry Context

The company's focus on mRNA genomics and machine learning AI aligns with current trends in the biotechnology and healthcare industries, where these technologies are being increasingly used for disease prevention and treatment.

Stakeholder Impact

• Shareholders will see a change in the company's name and potentially the trading symbol and CUSIP number of their stock.
• The company believes the name change will better reflect its business operations and strategies, potentially benefiting shareholders in the long term.

Next Steps

• File the Amendment to the Articles of Incorporation with the Nevada Secretary of State.
• Obtain FINRA approval for the corporate name change.
• File a Current Report on Form 8-K with the SEC to announce the new CUSIP number and trading symbol.

Key Dates

Keywords

Revealia, Inc., Ludwig Enterprises, Inc., corporate name change, shareholder approval, mRNA genomics, machine learning AI, chronic inflammation